← back to database
Altitude Life Science Ventures backs early-stage companies built on proprietary advances in biology or chemistry. Its mandate includes therapeutics and diagnostics, gene editing, computational and autonomous science, medical devices, drug-delivery platforms, dermatology, sequencing, and industrial applications of life-science technology.
Stage focus
Lead / follow
Check size
Specialization
Generalist / Specialist
Specialist
Latest fund size
$60M (Fund IV)
Latest fund vintage
2020
Investing team
- Dave MakiManaging Partner
- Kristen WongPartner
Notable investments
Altos Labs, Generate Biomedicines, Tessera Therapeutics, Lila Sciences, Ansa Biotechnologies, Ring Therapeutics, Bionaut Labs, Mozart Therapeutics, Aera Therapeutics
Sources
altitudelsv.com/about ↗altitudelsv.com/team ↗altitudelsv.com/fund-iv ↗sec.gov/Archives/edgar/data/1830429/000183042920000001/0001830429-20-000001-index.htm ↗s3.documentcloud.org/documents/21200589/202202_apfc-follow-up-to-sfin-on-jan-26_with-attachments.pdf ↗pipeseed.com/investor/altitude-life-science-ventures-204181 ↗